Effect of Eligible Patients Paper-based Reminder for General Practitioners on Colorectal Cancer Screening Participation
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Screening
Patient's participation to colorectal cancer screening program
Patient's status with colorectal cancer screening program to 15th june 2011 with two modalities Update: completion of Faecal Occult Blood test or exclusion for medical reason within the duration of the study (The medical exclusions of the program are a personal or family history of Colorectal cancer, Crohn's disease, hemorrhagic rectocolitis, or hereditary nonpolyposis colorectal cancer, a colonoscopy undergone in the 5 previous years or a Fecal Occult Blood test undergone in the 2 previous years) Not update
1 year
No
Julien Le Breton, MD, MPH
Principal Investigator
DUERMG
France: Committee for the Protection of Personnes
DUERMG
NCT01364454
June 2010
June 2011
Name | Location |
---|